Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Retinal Pathology”

679 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 679 results

Large-scale testing (Phase 3)Study completedNCT00473330
What this trial is testing

Ranibizumab Injection in Subjects With Clinically Significant Macular Edema (ME) With Center Involvement Secondary to Diabetes Mellitus (RISE)

Who this might be right for
Diabetes MellitusMacular Edema
Genentech, Inc. 377
Testing effectiveness (Phase 2)Study completedNCT00376701
What this trial is testing

Combination Therapy for Age-Related Macular Degeneration.

Who this might be right for
Age Related Macular Degeneration
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 103
Not applicableStudy completedNCT05456581
What this trial is testing

Scotoma Perimetry Oculomotor Training

Who this might be right for
Macular DegenerationCentral Visual Impairment
University of Alabama at Birmingham 21
Not applicableStudy completedNCT05598008
What this trial is testing

Effects of Glucagon-like-Peptide-1 Analogues on Sexuality

Who this might be right for
Sexual Desire
University Hospital, Basel, Switzerland 85
Testing effectiveness (Phase 2)WithdrawnNCT00696592
What this trial is testing

Photodynamic Therapy Combined With Bevacizumab vs Bevacizumab Alone for Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
University of Padova
Large-scale testing (Phase 3)Ended earlyNCT01940887
What this trial is testing

Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Either Avastin® or Eylea® Compared to Avastin® or Eylea® Monotherapy

Who this might be right for
Age-Related Macular Degeneration
Ophthotech Corporation 645
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Large-scale testing (Phase 3)Not Yet RecruitingNCT07496567
What this trial is testing

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-003)

Who this might be right for
Macular DegenerationAge-Related Macular DegenerationChoroidal Neovascularization+1 more
EyeBiotech Ltd. 960
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Not applicableStudy completedNCT02966145
What this trial is testing

4-Repeat Tauopathy Neuroimaging Initiative - Cycle 2

Who this might be right for
Corticobasal Degeneration (CBD)Corticobasal Syndrome (CBS)Cortical-basal Ganglionic Degeneration (CBGD)+3 more
University of California, San Francisco 293
Not applicableUnknownNCT05637385
What this trial is testing

Training Oculo-motor Control to Improve Vision When Using a Preferred Retinal Locus

Who this might be right for
Central Visual Impairment
Russell L. Woods 24
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Testing effectiveness (Phase 2)UnknownNCT00100087
What this trial is testing

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Theragenics Corporation 30
Not applicableStudy completedNCT03080714
What this trial is testing

Triton Agreement and Precision Study

Who this might be right for
Healthy EyesEye Diseases
Topcon Medical Systems, Inc. 88
Not applicableLooking for participantsNCT05355415
What this trial is testing

Adaptive Optics Imaging of Outer Retinal Diseases

Who this might be right for
Retinal DegenerationAge-Related Macular DegenerationRetinitis Pigmentosa+7 more
Food and Drug Administration (FDA) 100
Not applicableActive Not RecruitingNCT05698316
What this trial is testing

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

Who this might be right for
Age Related Macular DegenerationIntermediate AMDAtrophy+1 more
Association for Innovation and Biomedical Research on Light and Image 1,000
Large-scale testing (Phase 3)Study completedNCT01203436
What this trial is testing

Supplemental Therapeutic Oxygen for Prethreshold Retinopathy of Prematurity

Who this might be right for
Infant, NewbornInfant, Low Birth WeightInfant, Small for Gestational Age+3 more
NICHD Neonatal Research Network 649
Not applicableStudy completedNCT03052881
What this trial is testing

Robotic Retinal Dissection Device Trial

Who this might be right for
Epiretinal MembraneRetinal Hemorrhage
University of Oxford 24
Not applicableUnknownNCT01273792
What this trial is testing

Investigation of Biomarkers in Susac Syndrome

Who this might be right for
Susac Syndrome
Charite University, Berlin, Germany 30
Testing effectiveness (Phase 2)Looking for participantsNCT06789445
What this trial is testing

Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

Who this might be right for
Primary Photoreceptor DiseaseRetinitis Pigmentosa (RP)Usher Syndrome+6 more
BlueRock Therapeutics 54
Load More Results